These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 10356625

  • 21. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF, Prudic J, Rothpearl A, Nurnberg HG.
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [Abstract] [Full Text] [Related]

  • 22. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
    Duval F, Mokrani MC, Monreal J, Bailey P, Valdebenito M, Crocq MA, Macher JP.
    Psychoneuroendocrinology; 2003 Jul; 28(5):627-42. PubMed ID: 12727131
    [Abstract] [Full Text] [Related]

  • 23. Activity of the hypothalamic-pituitary-adrenal axis is altered by aging and exposure to social stress in female rhesus monkeys.
    Gust DA, Wilson ME, Stocker T, Conrad S, Plotsky PM, Gordon TP.
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2556-63. PubMed ID: 10902808
    [Abstract] [Full Text] [Related]

  • 24. The low dose dexamethasone suppression test: effect of time of administration and dose.
    Barton C, March S, Wittert GA.
    J Endocrinol Invest; 2002 Apr; 25(4):RC10-2. PubMed ID: 12030615
    [Abstract] [Full Text] [Related]

  • 25. Neonatal handling permanently alters hypothalamic-pituitary- adrenal axis function, behaviour, and body weight in boars.
    Weaver SA, Aherne FX, Meaney MJ, Schaefer AL, Dixon WT.
    J Endocrinol; 2000 Mar; 164(3):349-59. PubMed ID: 10694375
    [Abstract] [Full Text] [Related]

  • 26. Dexamethasone suppression test and plasma dexamethasone levels in bulimia.
    Walsh BT, Lo ES, Cooper T, Lindy DC, Roose SP, Gladis M, Glassman AH.
    Arch Gen Psychiatry; 1987 Sep; 44(9):797-800. PubMed ID: 3632253
    [Abstract] [Full Text] [Related]

  • 27. Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features.
    Kaneko M, Yokoyama F, Hoshino Y, Takahagi K, Murata S, Watanabe M, Kumashiro H.
    Neuropsychobiology; 1992 Sep; 25(1):1-7. PubMed ID: 1351264
    [Abstract] [Full Text] [Related]

  • 28. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ, Vaughn WK, Stone WJ.
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [Abstract] [Full Text] [Related]

  • 29. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
    Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
    [Abstract] [Full Text] [Related]

  • 30. Assessment of hypothalamic-pituitary-adrenal axis and sympathetic nervous system activity in pregnant sows through the measurement of glucocorticoids and catecholamines in urine.
    Hay M, Meunier-Salaün MC, Brulaud F, Monnier M, Mormède P.
    J Anim Sci; 2000 Feb 15; 78(2):420-8. PubMed ID: 10709934
    [Abstract] [Full Text] [Related]

  • 31. Dexamethasone suppression test in schizophrenic patients: report from India.
    Joseph S, Kulhara P, Dash RJ.
    Biol Psychiatry; 1987 Jun 15; 22(6):792-5. PubMed ID: 3593821
    [No Abstract] [Full Text] [Related]

  • 32. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
    Menke A, Arloth J, Best J, Namendorf C, Gerlach T, Czamara D, Lucae S, Dunlop BW, Crowe TM, Garlow SJ, Nemeroff CB, Ritchie JC, Craighead WE, Mayberg HS, Rex-Haffner M, Binder EB, Uhr M.
    Psychoneuroendocrinology; 2016 Jul 15; 69():161-71. PubMed ID: 27107207
    [Abstract] [Full Text] [Related]

  • 33. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder.
    Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH.
    Br J Psychiatry; 2004 Jun 15; 184():496-502. PubMed ID: 15172943
    [Abstract] [Full Text] [Related]

  • 34. Dexamethasone suppression test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport.
    Slotkin TA, Hays JC, Nemeroff CB, Carroll BJ.
    Depress Anxiety; 1997 Jun 15; 6(1):19-25. PubMed ID: 9394871
    [Abstract] [Full Text] [Related]

  • 35. HPA axis dysfunction in major depression: relationship to 5-HT(1A) receptor activity.
    Pitchot W, Herrera C, Ansseau M.
    Neuropsychobiology; 2001 Jun 15; 44(2):74-7. PubMed ID: 11490174
    [Abstract] [Full Text] [Related]

  • 36. Dexamethasone suppression test in autistic children.
    Hoshino Y, Ohno Y, Murata S, Yokoyama F, Kaneko M, Kumashiro H.
    Folia Psychiatr Neurol Jpn; 1984 Jun 15; 38(4):445-9. PubMed ID: 6535745
    [Abstract] [Full Text] [Related]

  • 37. Reproducibility of the low dose dexamethasone suppression test: comparison between direct plasma and salivary cortisol assays.
    Reynolds RM, Bendall HE, Whorwood CB, Wood PJ, Walker BR, Phillips DI.
    Clin Endocrinol (Oxf); 1998 Sep 15; 49(3):307-10. PubMed ID: 9861320
    [Abstract] [Full Text] [Related]

  • 38. The dex/CRH test--is it better than the DST?
    Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH.
    Psychoneuroendocrinology; 2006 Aug 15; 31(7):889-94. PubMed ID: 16701957
    [Abstract] [Full Text] [Related]

  • 39. Cognitive impairment and cortisol levels in first-episode schizophrenia patients.
    Havelka D, Prikrylova-Kucerova H, Prikryl R, Ceskova E.
    Stress; 2016 Jul 15; 19(4):383-9. PubMed ID: 27320489
    [Abstract] [Full Text] [Related]

  • 40. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW.
    Arch Gen Psychiatry; 2009 Jun 15; 66(6):617-26. PubMed ID: 19487626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.